- This topic is empty.
-
Posts
-
Introduction
In the ever-evolving landscape of biopharmaceuticals, Kexing Biopharm stands at the forefront, pioneering advancements in the integration of research and development, production, and sales of innovative drugs. With a robust focus on therapeutic areas such as antivirus, antitumor, immunosuppressant, kidney and digestive, Kexing Biopharm is not just a company; it's a beacon of hope for patients worldwide.
The Power of Biotechnology
At Kexing Biopharm, the commitment to innovation is unwavering. The company's dedication to building state-of-the-art biotechnology platforms, including new proteins, new antibodies, and nucleic acid drugs, underscores its mission to improve health outcomes globally. By adopting a platform-driven development model that emphasizes both innovation and internationalization, Kexing Biopharm is not only shaping the future of biopharmaceuticals but also expanding its reach to serve a broader patient base.
A Milestone in Biosimilar Development
On July 14, 2021, a significant milestone was achieved with the approval of Infliximab for Injection (Reminton) by the National Medical Products Administration (NMPA). This marked the introduction of the first infliximab biosimilar to the Chinese market, a testament to Kexing Biopharm's and their partners prowess in the field of biosimilars. Reminton, a recombinant anti-TNF-alpha chimeric monoclonal antibody, leverages the CHO cell expression system to deliver a product with proven efficacy, enhanced safety, and reduced immunogenicity as demonstrated through rigorous clinical studies.
Expanding Access to Life-Changing Therapies
The introduction of Reminton is more than just a commercial success; it represents a significant step forward in making advanced therapies accessible to a wider patient population. With indications for a range of conditions including Crohn's disease in adults and children over six years of age, ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis, Reminton offers new hope for individuals suffering from these debilitating conditions.
The Role of Infliximab Biosimilars in Modern Medicine
Infliximab biosimilars, such as Reminton, play a crucial role in modern medicine by offering alternative treatment options that are not only effective but also more affordable. This accessibility is crucial for patients who may have limited options due to the high costs associated with biologic therapies. By providing a biosimilar alternative, Kexing Biopharm is contributing to a more equitable healthcare system.
Clinical Evidence and Safety Profile
The clinical studies supporting Reminton's approval have been meticulous, ensuring that the biosimilar meets the highest standards of safety and efficacy. With a comprehensive understanding of its safety profile, healthcare providers can confidently prescribe Reminton, knowing that it has been thoroughly vetted through scientific research.
Global Impact and Future Prospects
Kexing Biopharm's commitment to internationalization is evident in its pursuit of global regulatory approvals and partnerships. The company's vision extends beyond national borders, aiming to make a significant impact on the global healthcare landscape. As Kexing Biopharm continues to explore new applications of biotechnology in general health and cultivate new industries, its influence in the biopharmaceutical sector is set to grow.
Conclusion
Kexing Biopharm's journey with the infliximab biosimilar is a story of innovation, dedication, and a relentless pursuit of improving patient outcomes. As the company continues to develop and market biosimilars, it is not only revolutionizing the way we approach treatment for various diseases but also setting a precedent for what biopharmaceutical companies can achieve. With a robust pipeline and a clear vision for the future, Kexing Biopharm is poised to lead the way in the high-quality biopharmaceutical sector, serving patients not just in China but around the world.
https://www.kexingbiopharm.com/medicines/infliximab-for-injection.html
Kexing Biopharm
- You must be logged in to reply to this topic.